6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3-carboxylic acid

Catalog No. :
ACBVZF019
CAS No. :
2751615-20-8
Molecular Formula :
C12H19NO4
Molecular Weight :
241.13

IUPAC Name:6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3-carboxylic acid

6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$750.00Login to see priceIn stockInquiry
250mg98%$1500.00Login to see priceIn stockInquiry
500mg98%$2249.00Login to see priceIn stockInquiry
1g98%$3749.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3-carboxylic acid
IUPAC Name6-(tert-butoxycarbonyl)-6-azabicyclo[3.1.1]heptane-3-carboxylic acid
MDL No.MFCD34595042
Molecular FormulaC12H19NO4
Molecular Weight241.13
SMILESO=C(N1C2CC(CC1C2)C(O)=O)OC(C)(C)C
InChI KeyOTKHJKUNLZISJV-UHFFFAOYSA-N
Synonym6-Azabicyclo[3.1.1]heptane-3,6-dicarboxylic acid, 6-(1,1-dimethylethyl) ester;6-Aza-bicyclo[3.1.1]heptane-3,6-dicarboxylic acid 6-tert-butyl ester;6-Boc-6-azabicyclo[3.1.1]heptane-3-carboxylic Acid
CAS No.2751615-20-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBVZF019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBVZF019 route product structure diagram
    ACBVZF0192751615-20-8 In Stock
Inquiry

2. ACBVZF019 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBVZF019 route product structure diagram
    ACBVZF0192751615-20-8 In Stock
Inquiry

Comments (0)